{"nct_id":"NCT04161495","title":"A Phase 3 Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein, Efanesoctocog Alfa (BIVV001), in Patients With Severe Hemophilia A","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2019-11-19","start_date_type":"ACTUAL","primary_completion_date":"2022-02-03","primary_completion_date_type":"ACTUAL","completion_date":"2022-02-03","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}